Abstract:The knock out of adenosine triphosphate (ATP) release channel (Panx1, Calhm2) and IP3R2, which could lead to the decreased extracellular ATP concentration, will exert depressive‐like effects. This means extracellular ATP may play an important role in depression. Purinergic receptors play vital roles in depression. The activation of P2X2R and P2X4R may play important roles in anti‐depressant effects, while P2X7R signaling could potentially promote the development of depressive‐like behaviors. Both A1 receptors and A2a receptors have been found to play a significant role in depression. A2a receptor antagonists have been reported to have clear anti‐depressant effects. Background Depression is a prevalent psychiatric disorder with high long‐term morbidities, recurrences, and mortalities. Despite extensive research efforts spanning decades, the cellular and molecular mechanisms of depression remain largely unknown. What's more, about one third of patients do not have effective anti‐depressant therapies, so there is an urgent need to uncover more mechanisms to guide the development of novel therapeutic strategies. Adenosine triphosphate (ATP) plays an important role in maintaining ion gradients essential for neuronal activities, as well as in the transport and release of neurotransmitters. Additionally, ATP could also participate in signaling pathways following the activation of postsynaptic receptors. By searching the website PubMed for articles about "ATP and depression" especially focusing on the role of extracellular ATP (eATP) in depression in the last 5 years, we found that numerous studies have implied that the insufficient ATP release from astrocytes could lead to depression and exogenous supply of eATP or endogenously stimulating the release of ATP from astrocytes could alleviate depression, highlighting the potential therapeutic role of eATP in alleviating depression. Aim Currently, there are few reviews discussing the relationship between eATP and depression. Therefore, the aim of our review is to conclude the role of eATP in depression, especially focusing on the evidence and mechanisms of eATP in alleviating depression. Conclusion We will provide insights into the prospects of leveraging eATP as a novel avenue for the treatment of depression.

The ATP Level in the mPFC Mediates the Antidepressant Effect of Calorie Restriction

The ATP Level in the Medial Prefrontal Cortex Regulates Depressive-like Behavior Via the Medial Prefrontal Cortex-Lateral Habenula Pathway.

The ATP level in the medial prefrontal cortex regulates depressive-like behaviour via the mPFC-LHb pathway

Caloric Restriction, Friend or Foe: Effects on Metabolic Status in Association with the Intestinal Microbiome and Metabolome

Calhm2 Governs Astrocytic ATP Releasing in the Development of Depression-Like Behaviors

The Effects of Calorie Restriction in Depression and Potential Mechanisms.

The neurobiological mechanisms and therapeutic prospect of extracellular ATP in depression

PGAM5 knockout causes depressive-like behaviors in mice via ATP deficiency in the prefrontal cortex

Mechanisms underpinning AMP-activated protein kinase-related effects on behavior and hippocampal neurogenesis in an animal model of depression

Thioredoxin Interacting Protein Drives Astrocytic Glucose Hypometabolism in Corticosterone‐induced Depressive State

Hippocampal CD 39/ ENTPD 1 Promotes Mouse Depression‐like Behavior Through Hydrolyzing Extracellular ATP

Effects of resveratrol on the levels of ATP, 5-HT and GAP-43 in the hippocampus of mice exposed to chronic unpredictable mild stress

Genetic and Pharmacological Inhibition of Astrocytic Mysm1 Alleviates Depressive‐Like Disorders by Promoting ATP Production

Loss of AMP-Activated Protein Kinase-α2 Impairs the Insulin-Sensitizing Effect of Calorie Restriction in Skeletal Muscle

Glibenclamide restores dopaminergic reward circuitry in obese mice through interscauplar brown adipose tissue

High, in Contrast to Low Levels of Acute Stress Induce Depressive-like Behavior by Involving Astrocytic, in Addition to Microglial P2X7 Receptors in the Rodent Hippocampus

Prophylactic nicotinamide mononucleotide (NMN) mitigates CSDS-induced depressive-like behaviors in mice via preserving of ATP level in the mPFC

Inhibition of Ampk Accentuates Prolonged Caloric Restriction-Induced Change in Cardiac Contractile Function Through Disruption of Compensatory Autophagy

Electroacupuncture-Modulated Extracellular ATP Levels in Prefrontal Cortex Ameliorated Depressive-like Behavior of Maternal Separation Rats

The Role of Nitric Oxide in the Antidepressant Actions of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside in Insulin-Resistant Mice

ATP reduces mitochondrial MECR protein in liver of diet-induced obese mice in mechanism of insulin resistance.